Novavax IncAdd to My Watchlist

NVAX:USNASDAQ GSIndustry: Medical-Biomedical/Gene
  • 1.24
    Last
  • 0.02  1.64%
    Today's Change
  • 1.22
    Previous Close
  • Today
     
    1.16
    8.49
    52 Week Low - High
5:20 pm ET 3/22/2017
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding272 million
Market Cap$337 million
Return on Equity ttm-144.75%
Last DividendNVAX:US does not pay a dividend
Earnings
EPS: Year Actual ttm-1.030
EPS: Year Est. 12/17 ttm-0.620
 
EPS: Quarterly Actual 12/16 -0.21
EPS: Quarterly Est. 3/17 -0.17
 
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate-71.67
Company Description
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Revenue$15 million
Net Income$-280 million
Total Assets$386 million
Employees443
Web Sitewww.novavax.com

Latest Headlines

No news available.

    Watchlist

    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now

     

    Not Registered?

    Get complete access to The Washington Post online - it's FREE!